These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7357319)

  • 1. Multiple sclerosis: what can and cannot be done.
    Poser S; Poser W
    Br Med J; 1980 Jan; 280(6208):184. PubMed ID: 7357319
    [No Abstract]   [Full Text] [Related]  

  • 2. The Field test controversy.
    Stoof JC; Koetsier JC
    Lancet; 1979 Jun; 1(8131):1402. PubMed ID: 87855
    [No Abstract]   [Full Text] [Related]  

  • 3. The Field test controversy.
    Caspary EA; Hughes D
    Lancet; 1979 Jun; 1(8131):1402-3. PubMed ID: 87856
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory tests for multiple sclerosis.
    Lancet; 1979 Jul; 2(8134):131-2. PubMed ID: 88561
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple sclerosis.
    Millar JH
    Br Med J; 1980 Jan; 280(6208):184-5. PubMed ID: 7357321
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Diagnostic test for multiple sclerosis.
    Foster JB; Mertin J; Thomson AM
    Br Med J; 1974 Mar; 1(5905):452. PubMed ID: 4816860
    [No Abstract]   [Full Text] [Related]  

  • 7. [MaxEpa in multiple sclerosis].
    Cendrowski W
    Wiad Lek; 1985 Nov; 38(21):1522-5. PubMed ID: 3913158
    [No Abstract]   [Full Text] [Related]  

  • 8. Omega-3 fatty acids and multiple sclerosis: relationship to depression.
    Aupperle RL; Denney DR; Lynch SG; Carlson SE; Sullivan DK
    J Behav Med; 2008 Apr; 31(2):127-35. PubMed ID: 18157629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of polyenoic fatty acids by red blood cells.
    Kühn H; Ludwig P; Salzmann-Reinhardt U; Höhne M; Rapoport SM
    Biomed Biochim Acta; 1987; 46(2-3):S156-9. PubMed ID: 3109404
    [No Abstract]   [Full Text] [Related]  

  • 10. The composition of fatty acids of the serum and erythrocytes after an alimentary cholesterol load.
    Grójec M; Kaleta Z
    Acta Physiol Pol; 1984; 35(2):177-84. PubMed ID: 6537129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of linoleate and arachidonate in red blood cells of healthy individuals and patients with multiple sclerosis.
    Homa ST; Belin J; Smith AD; Monro JA; Zilkha KJ
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):106-10. PubMed ID: 7359147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-chain polyunsaturated fatty acids in the erythrocyte lipids of breast-fed and bottle-fed infants [proceedings].
    Sanders TA; Naismith DJ
    Proc Nutr Soc; 1976 Sep; 35(2):63A-65A. PubMed ID: 987589
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis.
    Cuypers J; Reddemann H
    J Neurol Neurosurg Psychiatry; 1980 Nov; 43(11):995-8. PubMed ID: 7441283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical aspects of lipid metabolism in multiple sclerosis].
    Caputo D; Bisaccia G; Manara F; Zibetti A; Ghezzi A
    Arch Sci Med (Torino); 1978; 135(4):473-6. PubMed ID: 389199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.
    Holman RT; Johnson SB; Kokmen E
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4720-4. PubMed ID: 2734316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of diet in multiple sclerosis: A review.
    Esposito S; Bonavita S; Sparaco M; Gallo A; Tedeschi G
    Nutr Neurosci; 2018 Jul; 21(6):377-390. PubMed ID: 28338444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polyunsaturated fatty acids for multiple sclerosis treatment: scientific evidence].
    Kong-González M; Pérez-Cortéz JG; Hernández-Girón C; Macías-Morales N; Flores-Aldana M
    Medwave; 2015 Jan; 15(1):e6062. PubMed ID: 25628005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsaturated fatty acids in multiple sclerosis.
    Mertin J; Shenton BK; Field EJ
    Br Med J; 1973 Jun; 2(5869):777-8. PubMed ID: 4718333
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple sclerosis: what can and cannot be done.
    Field EJ; Joyce G
    Br Med J; 1980 May; 280(6225):1230. PubMed ID: 6248156
    [No Abstract]   [Full Text] [Related]  

  • 20. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1978 Nov; 2(6149):1390-1. PubMed ID: 363236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.